Literature DB >> 19507085

[New aspects in the management of exudative age-related macular degeneration - current position of the Retinological Society, the German Ophthalmology Society and the Professional Union of Ophthalmologists in Germany].

.   

Abstract

The socioeconomic strategy and some scientific aspects in the management of exudative age related macular degeneration (AMD) have changed since the last publication on preferred practice pattern. Furthermore new drugs are tested in clinical trials. Consequently it seems reasonable to re-evaluate the recommendations for the treatment of exudative AMD.

Entities:  

Mesh：

Year:  2009        PMID： 19507085     DOI： 10.1055/s-0028-1109432

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN： 0023-2165            Impact factor:   0.700


  3 in total

1.  [Anti-VEGF therapy for neovascular age-related macular degeneration -therapeutic strategies: statement of the German Ophthalmological Society, the German Retina Society and the Professional Association of Ophthalmologists in Germany - November 2014].

Authors: 
Journal:  Ophthalmologe       Date:  2015-03       Impact factor: 1.059

2.  Evidence for a considerable decrease in total and cause-specific incidences of blindness in Germany.

Authors:  Heiner Claessen; Jutta Genz; Bernd Bertram; Christoph Trautner; Guido Giani; Iris Zöllner; Andrea Icks
Journal:  Eur J Epidemiol       Date:  2012-06-19       Impact factor: 8.082

3.  Cooperation of German ophthalmologists in routine care of patients with neovascular age-related macular degeneration: results of the non-interventional BRIDGE study.

Authors:  Joachim Wachtlin; Andreas Ringwald; Tobias Maulhardt; Karin Pohl; Annette Wiedon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-12-17       Impact factor: 3.117
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.